Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Receivables (2025 - 2026)

Updated

Crinetics Pharmaceuticals' Receivables came in at $11.96 million for Q2 2026, up 110.4% from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) Receivables (2025 - 2026) Analysis & Trends

At the end of FY2025, Crinetics Pharmaceuticals' Receivables was $592,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn 11.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.96 Mn
Mar 31, 2026 5.68 Mn
Dec 31, 2025 592,000.00
API Access

Crinetics Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=CRNX&period=max&api_key=YOUR_API_KEY